Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Capital Markets

<ul><li>Consumer goods companies are currently facing their fair share of challenges in terms of rising input costs associated with the U.S. inflation being at an all-time high (close to 6.8%), labor issues, and supply chain problems.</li><li>Both these companies enjoyed their fair share of benefits during the pandemic lockdowns with their product range being classified in the 'essentials' category.</li><li>However, it would be interesting to place them side-by-side and evaluate the more financially robust player of the two.</li></ul>

Consumer goods companies are currently facing their fair share of challenges in terms of rising input costs associated with the U.S. inflation being at an all-time high (close to 6.8%), labor issues, and supply chain problems.Both these companies enjoyed their fair share of benefits during the pandemic lockdowns with their product range being classified in the 'essentials' category.However, it would be interesting to place them side-by-side and evaluate the more financially robust player of the two.

Procter & Gamble vs. Kimberly-Clark: Which Consumer Goods Major Is Financially More Stable? (12/2021)

<ul><li>Like most consumer goods companies, Kimberly-Clark continued its battle with inflationary pressures during the quarter and delivered below-par earnings.</li><li>The company is suffering from supply chain disruptions and rising input costs.</li><li>Its Consumer Tissue segment has been the only lacklustre performer on the revenue front with a 5% drop in revenues.</li></ul>

Like most consumer goods companies, Kimberly-Clark continued its battle with inflationary pressures during the quarter and delivered below-par earnings.The company is suffering from supply chain disruptions and rising input costs.Its Consumer Tissue segment has been the only lacklustre performer on the revenue front with a 5% drop in revenues.

Value Investing

Vladimir Dimitrov, CFA

Equity Bottom-Up

<ul>
<li>Kimberly-Clark has been among the worst-performing large-cap consumer staple businesses.</li>
<li>Even though management is executing well, the strategic positioning of the business remains weak.</li>
<li>Dividend increases appear unlikely, which does not bode well for returns given the inflationary environment.</li>
</ul>


Kimberly-Clark has been among the worst-performing large-cap consumer staple businesses.
Even though management is executing well, the strategic positioning of the business remains weak.
Dividend increases appear unlikely, which does not bode well for returns given the inflationary environment.


Kimberly-Clark: Strategic Positioning Matters

<ul><li>Kimberly-Clark suffered from a weak result which was a stark contrast to the company’s record strong growth in the year-ago quarter.</li><li>The company failed to meet analyst expectations in terms of revenues as well as earnings and the only silver lining was the personal care organic sales growing by 6% worldwide, driven by a 4% volume increase.</li><li>The company saw a decent personal care organic sales performance in markets like China, Brazil, Eastern Europe, Peru, India, and South Africa.</li></ul>

Kimberly-Clark suffered from a weak result which was a stark contrast to the company’s record strong growth in the year-ago quarter.The company failed to meet analyst expectations in terms of revenues as well as earnings and the only silver lining was the personal care organic sales growing by 6% worldwide, driven by a 4% volume increase.The company saw a decent personal care organic sales performance in markets like China, Brazil, Eastern Europe, Peru, India, and South Africa.

<ul><li>Since I first covered Kimberly-Clark back in June of last year, the total return has been disappointing, to say the least.</li><li>Rising commodity prices are proving to be a headwind for all Personal &amp; Home Care companies, however, KMB is hit disproportionally.</li><li>Kimberly-Clark is at a competitive disadvantage to its peers, which could have a lasting impact on returns.</li></ul>

Since I first covered Kimberly-Clark back in June of last year, the total return has been disappointing, to say the least.Rising commodity prices are proving to be a headwind for all Personal &amp; Home Care companies, however, KMB is hit disproportionally.Kimberly-Clark is at a competitive disadvantage to its peers, which could have a lasting impact on returns.

Kimberly-Clark Did Underperform, I Don't See This Changing

United States

Kimberly-Clark Corporation is a global health and hygiene company that manufactures and provides consumer products. The Company's products include diapers, tissues, paper towels, incontinence care products, surgical gowns, and disposable face masks.  Kimberly-Clark's products are sold in countries around the world.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Kimberly Clark (KMB US)

Procter & Gamble vs. Kimberly-Clark: Which Consumer Goods Major Is Financially More Stable? (12/2021)

Consumer goods companies are currently facing their fair share of challenges in terms of rising input costs associated with the U.S. inflation...

Baptista Research

Kimberly-Clark Corp - Investment Thesis

Like most consumer goods companies, Kimberly-Clark continued its battle with inflationary pressures during the quarter and delivered below-par...

Baptista Research

Kimberly-Clark: Strategic Positioning Matters

Kimberly-Clark has been among the worst-performing large-cap consumer staple businesses. Even though management is executing well, the strategic...

Vladimir Dimitrov, CFA

Kimberly-Clark Corp - Investment Thesis

Kimberly-Clark suffered from a weak result which was a stark contrast to the company’s record strong growth in the year-ago quarter. The company...

Baptista Research

Kimberly-Clark Did Underperform, I Don't See This Changing

Since I first covered Kimberly-Clark back in June of last year, the total return has been disappointing, to say the least. Rising commodity prices...

Vladimir Dimitrov, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)